2023-05-03 17:13:58 ET
- Outset Medical press release ( NASDAQ: OM ): Q1 Non-GAAP EPS of -$0.72 misses by $0.03 .
- Revenue of $33.5M (+9.5% Y/Y) beats by $1.74M .
- Total cash, including restricted cash, cash equivalents and short-term investments, was $252.5 million as of March 31, 2023.
- Full Year 2023 Financial Guidance : Outset now projects revenue for 2023 to range from $144 million to $150 million vs. consensus of $144.85M, which represents approximately 25% to 30% growth over the Company's fiscal year 2022 revenue. This updated guidance compares to prior 2023 revenue guidance of $140 million to $150 million.
- In addition, the Company expects gross margin for the year to be in the low-20% range, up from its prior guidance of approximately 20%, and exiting the fourth quarter in the mid-20% range.
For further details see:
Outset Medical reports mixed Q1 earnings; updates FY23 outlook